MAPK3 and endometrial cancer: In another study, Yang et al. (2014) demonstrated that SERPINA3 drives endometrial cancer cell proliferation by regulating the G2/M cell cycle checkpoint, inhibiting apoptosis, and interacting with PI3K/AKT and MAPK/ERK1/2 signaling pathways [34].